Table 1. Histological and clinical classification of patient samples analyzed for Cx43 and/or ADORA1 expression.

ID	Tumor type	Year	Age (yr)	Menopausal status	Surgical removal
1	ND	1996	48.47	Pre	Mastectomy
2	IDC	1994	46.71	Pre	Mastectomy
3	IDC	1993	76.10	Post	Mastectomy
4	IDC	1992	39.85	Pre	Mastectomy
5	ND	1996	67.27	Post	Lumpectomy
6	IDC	1995	55.57	Post	Lumpectomy
7	IDC	1992	64.39	Post	Lumpectomy
8	IDC	1992	43.29	Pre	Lumpectomy
9	IDC	1993	47.90	Pre	Lumpectomy
10	IDC	1996	34.35	Pre	Mastectomy
11	ND	1995	30.50	Pre	Lumpectomy
12	IDC	1996	47.93	Pre	Mastectomy
13	IDC	1996	52.81	Post	Lumpectomy
14	ILC	1991	59.54	Post	Lumpectomy
15	IDC	1991	68.69	Post	Lumpectomy
16	IDC	1995	68.95	Post	Lumpectomy
17	IDC	1992	36.67	Pre	Lumpectomy
18	IDC	1993	76.51	Post	Lumpectomy
19	IDC	1995	80.56	Post	Mastectomy

Red shading indicates samples stained for Cx43, blue shading indicates samples stained for ADORA1, and green shading indicates samples stained for both Cx43 and ADORA1. IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma.